Philadelphia, PA (PRWEB) October 21, 2013
Olfactory Biosciences Corp.’s (OLFC) Chief Scientist Dr. V. Ruth Pinney invented proprietary NOXO Autism Balm™ to reduce coping behaviors. Dr. Pinney noted that what makes NOXO’s Autism Balm™ unique is that it, "Is a simple, but powerful way to ‘tone down’ their overwhelming perceptions. NOXO Autism Balm™ works well with most children that have Autism Spectrum Disorders (ASD). It is successful because it targets sensitivities naturally, changing the child's perception to sensory inputs in a direct, safe way!" http://www.noxoinfo.com/autism
“My 14-year old non-verbal autistic son is on the moderate to severe spectrum with mental retardation, obsessive-compulsive disorder, and ADHD. My wife and I deal with several behavioral issues on a daily basis like temper tantrums, slamming the doors, running out to the street, and a lot of self-stimulating. What attracted me with the NOXO Autism balm™ is that it is a topical application. I can easily apply it with no power struggle with him. It's been 10 days now and I am in disbelief how this product brought some tranquility in our home. My son is calmer and quieter and his behavioral issues are now down to 10%. Knowing that our brain controls everything including behaviors, it makes sense that this product can "tweak" the brain neurotransmitters to elicit a desired effect,” said A. A. Chang, RN, L A Sheriff Depart. (Former Pediatrician outside the USA)
Dr. Pinney explains, It works very well on its own or with other Autism Spectrum therapies as an adjunct. Autism Aid will also assist in supporting the child in eating a variety of nutritious foods. NOXO Autism Balm™ is similar to a lip balm but is applied just below the nostrils on the upper lip, allowing the natural formula to be inhaled and take effect.
NOXO Autism Balm™ is now priced at $ 29.95 for 100 doses….about $ 1 a day. Amazon Guaranteed http://www.noxoinfo.com/autism
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common behavior challenges such as anxiety, smoking or weight control, as examples. http://www.noxoinfo.com/investor.html
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Source: Olfactory Biosciences Corp